PROGENSA PCA3 is the first test to determine the presence of PCA3 to use to predict prostate cancer.

PROGENSA PCA3 is the first test to determine the presence of PCA3 to use to predict prostate cancer, and in conjunction with current tests to confirm the diagnosis are used. 1-4.

Diagnosing prostate cancer. Statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that could cause the actual results, performance or achievements of the company may differ materially from those expressed or implied by forward -looking statements. Information about the information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the quarter ended March 2007, and all subsequent periodic reports with the SEC made. We assume no obligation and obligation to update any obligation to update forward-looking statements to reflect events or circumstances after the date reflect reflect the occurrence of unanticipated events..Introduction of disease, Backyard Poultry flocculation owner, Canada? The Canadian Food Inspection Agency and which Minist acid de l’Agriculture, the P cheries et de l’Alimentation du Src bec invite owner from small and courtyard poultry attend an information session, like for preventing, seen and fowl diseases like bird flu attend.